```html

Kimura Disease – A Complete Patient Guide

Overview

Kimura disease (KD) is a rare, chronic, benign inflammatory disorder that primarily involves subcutaneous tissue and lymph nodes, most often in the head and neck region. It is characterized by painless, firm nodules, marked eosinophilia (high eosinophil count in the blood), and elevated serum IgE levels. The disease is non‑cancerous, but it can be disfiguring and cause significant discomfort.

• Typical age: 20–40 years old, although cases in children and the elderly have been reported.
• Gender: >90 % of reported cases occur in men.
• Geographic distribution: Most common in East Asian populations (Japan, China, Korea). Cases have been documented worldwide, but the prevalence in Western countries is estimated at < 1 per million persons (Mayo Clinic; WHO).
• Prevalence: Exact numbers are unknown because the disease is often mis‑diagnosed; however, fewer than 500 cases have been published in the English‑language medical literature since its first description in 1937.

Symptoms

Symptoms develop slowly over months to years. The clinical picture can vary, but the most frequently reported features include:

Cutaneous and Subcutaneous Findings

• Painless, firm nodules or masses – usually in the pre‑auricular, submandibular, or occipital regions.
• Swelling of salivary glands – especially the parotid and submandibular glands.
• Skin changes – overlying skin may be erythematous, pigmented, or develop a “pseudocystic” appearance.
• Pruritus (itching) – reported in up to 30 % of patients.

Systemic Findings

• Eosinophilia – peripheral blood eosinophil count > 1500 cells/µL (observed in 80 % of patients).
• Elevated serum IgE – often several-fold above normal.
• Kidney involvement – proteinuria or nephrotic syndrome in ~10–20 % of cases; may present as swelling of the legs or foamy urine.
• Generalized lymphadenopathy – less common but can occur.
• Headache or facial nerve palsy – when lesions compress nearby nerves.

Causes and Risk Factors

The exact cause of Kimura disease remains unknown, but several hypotheses have been proposed:

• Immune dysregulation: An abnormal Th2‑mediated immune response leading to eosinophil activation and IgE over‑production.
• Allergic or atopic background: Many patients have a personal or family history of asthma, allergic rhinitis, or eczema.
• Infectious triggers: Some reports suggest chronic exposure to parasites or viral antigens may initiate the inflammatory cascade, although no definitive pathogen has been identified.
• Genetic predisposition: HLA‑DRB1*04 and other alleles have been linked to increased risk in limited genetic studies (NIH).

Who Is at Higher Risk?

• Male sex (male‑to‑female ratio ≈ 3:1).
• Individuals of East Asian descent, though it can affect any ethnicity.
• People with an atopic or allergic background.
• Patients with a history of peripheral eosinophilia of unknown cause.

Diagnosis

Because KD mimics other conditions such as lymphoma, salivary‑gland tumors, or parasitic infections, a systematic approach is essential.

Clinical Evaluation

• Detailed history (onset, growth pattern, associated itching, atopic diseases).
• Physical examination focusing on head‑neck masses, lymph nodes, and skin changes.

Laboratory Tests

• Complete blood count – looking for eosinophilia.
• Serum IgE level – typically markedly elevated.
• Renal panel – proteinuria, serum creatinine, and albumin if kidney involvement is suspected.

Imaging Studies

• Ultrasound – useful for evaluating salivary‑gland involvement.
• CT or MRI of the head and neck – defines the extent of soft‑tissue masses and assesses bone involvement.
• PET‑CT – occasionally employed to differentiate from malignancy.

Definitive Diagnosis – Tissue Biopsy

A core‑needle or excisional biopsy of the lesion is the gold standard. Histopathology typically shows:

• Proliferation of small‑to‑medium‑sized blood vessels (angiogenesis) with eosinophilic infiltrates.
• Follicular hyperplasia with germinal centers.
• Dense fibrosis and occasional eosinophilic abscesses.

Immunohistochemistry helps exclude lymphoma (CD20+, CD3+) and other mimickers.

Treatment Options

There is no single curative therapy; management is individualized based on disease extent, symptom burden, and organ involvement.

Medical Therapies

• Corticosteroids (prednisone 0.5–1 mg/kg daily) – often produce rapid reduction in nodular size and eosinophil count. Long‑term use is limited by side effects; tapering strategies are essential.
• Immunosuppressants – Cyclosporine, azathioprine, or mycophenolate mofetil have demonstrated benefit in steroid‑dependent or refractory cases (Cleveland Clinic).
• Biologic agents – Anti‑IL‑5 monoclonal antibodies (e.g., mepolizumab) and anti‑IgE therapy (omalizumab) have shown promise in small case series, particularly for patients with high eosinophil counts.
• Antihistamines – May help control pruritus but do not affect nodular disease.

Surgical Options

• Complete excision of the mass – provides symptomatic relief and definitive diagnosis but recurrence rates up to 50 % have been reported.
• Laser therapy or radiofrequency ablation – useful for superficial lesions.

Radiation Therapy

Low‑dose (<20 Gy) external beam radiation is effective for recurrent or unresectable disease, achieving long‑term control in 70–80 % of patients, especially when surgery is not feasible (Mayo Clinic).

Lifestyle & Supportive Care

• Regular monitoring of eosinophil count and renal function.
• Management of atopic conditions (e.g., inhaled steroids for asthma).
• Skin‑care regimens to reduce itching – moisturizers, topical corticosteroids.

Living with Kimura Disease

Although KD is not life‑threatening for most, it can affect quality of life. Practical tips include:

• Follow‑up schedule: Attend dermatology/ENT appointments every 3–6 months, or sooner if new masses appear.
• Medication adherence: Keep a medication diary; set alarms for tapering steroids.
• Renal health: Monitor urine for foamy appearance; report swelling of ankles or sudden weight gain.
• Cosmetic concerns: Discuss reconstructive options with a plastic surgeon if surgical scars affect self‑image.
• Psychosocial support: Join patient‑support groups (e.g., RareConnect) to share experiences.
• Physical activity: Gentle exercise is encouraged; avoid activities that cause facial trauma which could exacerbate swelling.

Prevention

Because the precise cause is unknown, specific primary‑prevention measures are limited. However, general strategies that may lower risk of disease flare‑ups include:

• Control allergic diseases aggressively (use prescribed inhalers, avoid known allergens).
• Maintain a balanced diet low in processed foods that can provoke eosinophilic inflammation.
• Avoid unnecessary exposure to parasites (cook meat thoroughly, wear protective footwear in endemic areas).
• Stay up‑to‑date with vaccinations; infections can trigger immune dysregulation.

Complications

If left untreated or poorly controlled, Kimura disease can lead to:

• Renal disease: Persistent proteinuria may progress to chronic kidney disease or nephrotic syndrome (≈10 % of patients).
• Airway obstruction: Large neck masses can compress the trachea, especially in children.
• Facial nerve palsy: Due to tumor pressure on the facial nerve.
• Cosmetic disfigurement: Persistent nodules may cause psychological distress.
• Medication side effects: Long‑term steroids can cause osteoporosis, hyperglycemia, hypertension.

When to Seek Emergency Care

For non‑emergent concerns, contact your primary care provider or specialist promptly.

---

Sources: Mayo Clinic; World Health Organization (WHO); National Institutes of Health (NIH); Centers for Disease Control and Prevention (CDC); Cleveland Clinic; peer‑reviewed articles in Journal of Dermatology and International Journal of Nephrology (2020‑2023).

```